From: The effects of molar activity on [18F]FDOPA uptake in patients with neuroendocrine tumors
Background region | SUVmean [18]FFDOPA-L | SUVmean [18]FFDOPA-H | p value | Effect size r |
---|---|---|---|---|
Striatum | 1.21 (1.11–1.36) | 1.36 (1.09–1.49) | 0.011 | − 0.36a |
Heart | 1.52 (1.25–1.77) | 1.62 (1.39–1.85) | 0.006 | − 0.39a |
Aorta | 1.12 (1.04–1.22) | 1.18 (1.05–1.31) | 0.004 | − 0.40a |
Liver | 1.64 (1.45–1.74) | 1.67 (1.48–1.86) | 0.068 | − 0.26a |
Gallbladder | 2.65 (1–50-4.31) | 2.90(0.96–4.17) | 0.540 | − 0.09b |
Pancreas (head) | 1.66 (1.39–1.94) | 1.59 (1.34–1.89) | 0.255 | − 0.17b |
Pancreas (body) | 1.47 (1.19–1.75) | 1.53 (1.32–1.87) | 0.174 | − 0.20a |
Pancreas (tail) | 1.46 (1.22–1.73) | 1.55 (1.34–1.84) | 0.010 | − 0.38a |
Left kidney | 2.73 (2.36–3.04) | 2.83 (2.55–3.39) | 0.028 | − 0.31a |
Right kidney | 2.74 (2.45–3.02) | 2.99 (2.70–3.67) | 0.000* | − 0.59a |
Left adrenal gland | 2.12 (1.86–2.72) | 2.50 (1.98–3.26) | 0.000* | − 0.52a |
Right adrenal gland | 2.34 (1.83–3.05) | 2.49 (2.15–3.30) | 0.005 | − 0.41a |